UMC Posters

In focus / 23 October 2018

We publish and distribute a variety of well researched, informational posters for conferences and communications.


Here is a selection of some of our best posters. You are free to download, print and share them, but please credit the relevant authors and the UMC if you publish or display any of them and we would also appreciate it if you inform us.

Evaluation of a predictive model for suspected drug-drug interactions in routine signal detection by Sara Hult, Tomas Bergvall, Thomas Bradley, Lucie Gattepaille, Birgitta Grundmark, Daniele Sartori, Sara Hedfors Vidlin, G Niklas Norén, Johan Ellenius.

Interaction between rosuvastatin and ticagrelor resulting in rhabdomyolysis by Viola Macolic Sarinic, Lovisa Sandberg, Jenny Hartman, Pia Caduff-Janosa.

Unexpectedly high fatality rate in globally collected spontaneous reports of progressive multifocal leukoencephalopathy with alemtuzumab by Maarten van Eijk, Ola Caster.

Natalizumab and rapidly evolving central nervous system lymphoma in VigiBase by Daniele Sartori, Camilla Westerberg, Birgitta Grundmark.

Do they all agree? – Comparing expert signal assessment by Birgitta Grundmark. Daniele Sartori, Johan Ellenius.

Exploring patient reported information in signal detection within a global database by Sarah Watson, Rebecca Chandler, Henric Taavola, Linda Härmark, Birgitta Grundmark, Alem Zekarias, Kristina Star, Florence van Hunsel.

This poster won the first prize at the 2017 ISoP annual meeting. The production of this poster illustrates a successful collaboration internally between Research and Global Communications, and externally with the Dutch national centre, Lareb.

2+2=5:The future of evidence in a post-truth age of alternative facts by Bruce Hugman

Alexandra Hoegberg @alexhoegberg
Team Manager, Global Communications, UMC

You may also like


Guardians of Health: Vigilant surveillance of HIV and TB medicines in Namibia

The introduction of new medications for HIV and TB in Namibia required a more proactive hand in monitoring their safety. For the Namibian TWG, active surveillance was the answer.

In focus / 23 October 2023

Making fewer medication errors – Education and training remain key

Medication errors significantly contribute to the global number of ADRs per year. How may we best prepare the pharmacovigilance community to tackle the problem?

In focus / 02 April 2024

Empowering patients as partners – New podcast episode

A patient’s perspective can lead to new insights that traditional research may overlook. Yet how may we best harness their perspective to improve patient outcomes?

In focus / 06 September 2023

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more